We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROV icon
2901
Provident Financial
PROV
$113M
$8K ﹤0.01%
427
+47
+12% +$863
RDI icon
2902
Reading International Class A
RDI
$35.2M
$8K ﹤0.01%
523
-1,433
-73% -$22.8K
REI icon
2903
Ring Energy
REI
$354M
$8K ﹤0.01%
781
-6,231
-89% -$74.7K
RVSB icon
2904
Riverview Bancorp
RVSB
$107M
$8K ﹤0.01%
910
-841
-48% -$7.71K
RWJ icon
2905
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.09B
$8K ﹤0.01%
+300
New +$7.64K
SOHO
2906
DELISTED
Sotherly Hotels
SOHO
$8K ﹤0.01%
1,107
-3,853
-78% -$27.5K
STBA icon
2907
S&T Bancorp
STBA
$1.79B
$8K ﹤0.01%
189
-5,158
-96% -$233K
TCPC icon
2908
BlackRock TCP Capital
TCPC
$331M
$8K ﹤0.01%
548
+173
+46% +$2.53K
TSM icon
2909
TSMC
TSM
$2.17T
$8K ﹤0.01%
+187
New +$7.75K
VVX icon
2910
V2X
VVX
$2.6B
$8K ﹤0.01%
270
-1,127
-81% -$36.3K
WOOD icon
2911
iShares Global Timber & Forestry ETF
WOOD
$272M
$8K ﹤0.01%
+100
New +$7.69K
USAP
2912
DELISTED
Universal Stainless & Alloy
USAP
$8K ﹤0.01%
+338
New +$9.32K
ORAN
2913
DELISTED
Orange
ORAN
$8K ﹤0.01%
510
-7,452
-94% -$123K
ALIM
2914
DELISTED
Alimera Sciences
ALIM
$8K ﹤0.01%
517
+421
+439% +$6.41K
OSG
2915
DELISTED
Overseas Shipholding Group Inc.
OSG
$8K ﹤0.01%
2,604
+834
+47% +$2.91K
ALPN
2916
DELISTED
Alpine Immune Sciences Inc
ALPN
$8K ﹤0.01%
1,255
-82
-6% -$574
TRVN
2917
DELISTED
Trevena, Inc.
TRVN
$8K ﹤0.01%
+6
New +$6.05K
KDNY
2918
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8K ﹤0.01%
230
-1,022
-82% -$32.8K
ARDS
2919
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$8K ﹤0.01%
+625
New +$8.08K
AGTC
2920
DELISTED
Applied Genetic Technologies Corporation
AGTC
$8K ﹤0.01%
1,063
-18,897
-95% -$82.7K
CCXI
2921
DELISTED
ChemoCentryx, Inc.
CCXI
$8K ﹤0.01%
626
-6,167
-91% -$74.3K
ACBI
2922
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$8K ﹤0.01%
454
-221
-33% -$4.08K
DRNA
2923
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$8K ﹤0.01%
532
-265
-33% -$3.86K
BOCH
2924
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$8K ﹤0.01%
620
+552
+812% +$7K
MDLY
2925
DELISTED
Medley Management Inc
MDLY
$8K ﹤0.01%
152
-315
-67% -$14.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.5% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.